Skip to main content

Science prizes.

The Boehringer Ingelheim Foundation honours particularly outstanding scientific achievements with its science awards. Endowed with 100,000 euros, the Heinrich Wieland Prize honours distinguished scientists from around the world for their groundbreaking research on biologically active molecules and systems in the fields of chemistry, biochemistry, and physiology, as well as their clinical importance. Four of the Prize’s laureates have been subsequent Nobel Prize laureates.

The Foundation awards the Boehringer Ingelheim Prize to excellent and advanced early-career scientists at the University Medical Center of the University of Mainz. It has been presented annually since 1969 for excellence in clinical as well as theoretical medicine, and is endowed with a total of 30,000 euros in prize money.

Each year, the Foundation awards four PhD student prizes at the University of Mainz in recognition of particularly excellent dissertations or theses in biology, medicine, chemistry, and pharmacy.

2017 Heinrich Wieland Prize.

Professor Alexander Varshavsky, of the California Institute of Technology in Pasadena, USA, receives the 2017 Heinrich Wieland Prize for discovering the biology of the ubiquitin system, a set of pathways mediating, among other things, protein degradation.

The Boehringer Ingelheim Foundation will present him with the 100.000 euro award on 19 October 2017 in the course of a scientific symposium.

Programme of the award symposium

2017 Boehringer Ingelheim Prize.

Toxicologist Dr Jörg Fahrer found out, how cells of the colon react to certain cancer-causing agents that are produced, for example, while roasting meat and how the cell protects itself against damage to its DNA and damage-induced cell death. His results help to understand better how cancer of the colon develops.

Ophtomalogist Dr Katharina Ponto analyzed data from a large health study and thus delivered the first sound and informative numbers about retinal damage in very early-stage diabetes patients. Her data suggest that targeted screening programmes could help to prevent retinal damage due to diabetes.

Press release in German only.